Skip to main content
. 2021 May 4;21:356. doi: 10.1186/s12884-021-03817-2

Table 1.

Patient characteristics

Group I (n = 958) Group II (n = 588) Total (n = 1564) p
Age (years) 32.5 ± 5.1 32.5 ± 4.9 32.5 ± 5.0 0.702
Parity 2.4 ± 0.8 2.3 ± 0.8 2.4 ± 0.80 0.055
Gestational age (weeks) 39.0 ± 2.1 39.0 ± 2.1 39.1 ± 2.1 0.182
BMI (kg/m2) 25.4 ± 5.6 26.0 ± 6.2 25.7 ± 5.8 0.197
Previous vaginal birth 211 (28.7%) 136 (23.6%) 347 (26.4%) 0.036
Prostaglandin used 264 (27.6%) 213 (36.2%) 477 (30.9%) < 0.001
Oxytocin used 410 (42.9%) 160 (27.2%) 570 (36.9%) < 0.001
Oxytocin and prostaglandin used 117 (12.2%) 61 (10.4%) 178 (11.5%) 0.271
Gestational diabetes 110 (11.5%) 61 (10.4%) 171 (11.1%) 0.503
Hypertensive, pregnancy-related disease 51 (5.3%) 34 (5.8%) 85 (5.5%) 0.699
Birthweight of previous infant delivered by CD (g) 3049 ± 811 3059 ± 816 3052 ± 811 0.649
Neonatal weight (g) 3351 ± 587 3332 ± 586 3344 ± 586 0.757
Preterm birth (≤ 36 + 6 weeks of gestation) 114 (11.9%) 72 (12.2%) 186 (12.0%) 0.840
Median duration of the second stage of labor (minutes) (n = 789) 57.4 ± 56.3 65.4 ± 60.7 61.0 ± 58.5 0.098
Median duration of the second stage of labor (minutes) for patients with previous vaginal birth (n = 227) 28.3 ± 38.3 31.82 ± 42.3 29.91 ± 40.1 0.910
Median duration of the second stage of labor (minutes) for patients without previous vaginal birth (n = 560) 69.3 ± 58.2 79.3 ± 61.9 73.8 ± 60.0 0.045